Panmure Gordon, which has the stock rated as a buy at a target price of €16.50, said the airline’s long-term prospects remain “highly attractive”. (Photograph: Brendan McDermid/Reuters)

Stockbrokers have responded positively to Ryanair’s first half results, which saw the Irish airline’s pre-tax profits soar by 37 per cent to more tha(...)

James “Jes” Staley: is a Wall Street veteran, having spent more than 30 years at JP Morgan Chase. Photograph: Bloomberg

When Bob Diamond resigned from Barclays in the wake of the Libor-rigging scandal three years ago, a deep gloom descended over the group’s investment b(...)

Petra said the diamond was purchased by a partnership comprising itself and a polishing partner, who wished to remain anonymous

London-listed Petra Diamonds sold a rare blue diamond found at its mine in South Africa for $27.6 million, falling short of the price some analysts ha(...)

Pascal Soriot, chief executive of  AstraZeneca:  said the future of its neuroscience and anti-infection businesses was under review and he hoped to announce news “in the near future”.

Pascal Soriot has set out a manifesto for AstraZeneca’s continued independence by announcing the possible sale or spin-off of non-core units in(...)

Prudential shares rose as much as 2.2% after chief executive Tidjane Thiam announced new cash and growth targets in London

Prudential said yesterday it plans to generate £10 billion in cash in the four years through 2017, raising speculation the UK’s largest insurer by mar(...)

During a conference call yesterday, analysts grilled RSA directors about the implications of the two successive profit warnings on the insurer’s levels of debt, the adequacy of its controls and the possibility of disposals.

Shares in RSA dropped as much as 16 per cent yesterday as investors had their first chance to respond to accounting irregularities at the insurer’s Ir(...)

AstraZeneca sales in the quarter slid by 6 per cent to $6.25 billion, weighed down by the loss of patent protection on several drugs – including, in some markets, its top-selling cholesterol fighter Crestor – while EPS tumbled 28 per cent.

AstraZeneca has promoted Marc Dunoyer to be its new chief financial officer, plugging a gap in the British drugmaker’s top management team as it grapp(...)

The UK government seems to have been taken by surprise at the popularity of the Royal Mail offering, which is heavily oversubscribed and is expected to list at the top of its £3 to £3.30 a share band. Photograph: Paul Thomas/Bloomberg

London is in the throes of a 1980s revival. In Westminster, Tory politicians loudly extol the economic and moral virtues of privatisation, while City (...)

A G4S security van is parked outside a bank in  England yesterday. REUTERS/Darren Staples

G4S, the world’s largest security services firm, raised £348 million (€405m) through a share sale, with more to come from asset disposals, as its new (...)

UK housebuilders and mortgage lenders called for more clarity on how the government will wind down a support scheme for struggling housebuyers which has boosted developers’ profit forecasts amid fears of a new property bubble. Photograph:  REUTERS/Gary Cameron.

UK housebuilders and mortgage lenders called for more clarity on how the government will wind down a support scheme for struggling housebuyers which h(...)